|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/395 | |||
| A61P 35/00 |
| (11) | Number of the document | 3288980 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16724512.5 |
| Date of filing the European patent application | 2016-04-28 | |
| (97) | Date of publication of the European application | 2018-03-07 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/029878 |
| Date | 2016-04-28 |
| (87) | Number | WO 2016/176504 |
| Date | 2016-11-03 |
| (30) | Number | Date | Country code |
| 201562153954 P | 2015-04-28 | US |
| (72) |
YANG, Arvin, US
|
| (73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
| (54) | TREATMENT OF PD-L1-POSITIVE MELANOMA USING AN ANTI-PD-1 ANTIBODY |
| TREATMENT OF PD-L1-POSITIVE MELANOMA USING AN ANTI-PD-1 ANTIBODY |